Journal article
Utilizing SEER Cancer Registries for Population-Based Cancer Survivor Epidemiologic Studies: A Feasibility Study
Cancer epidemiology, biomarkers & prevention, Vol.29(9), pp.1699-1709
09/2020
DOI: 10.1158/1055-9965.EPI-20-0153
PMCID: PMC7484198
PMID: 32651214
Abstract
While the primary role of central cancer registries in the United States is to provide vital information needed for cancer surveillance and control, these registries can also be leveraged for population-based epidemiologic studies of cancer survivors. This study was undertaken to assess the feasibility of using the NCI's Surveillance, Epidemiology, and End Results (SEER) Program registries to rapidly identify, recruit, and enroll individuals for survivor research studies and to assess their willingness to engage in a variety of research activities.
In 2016 and 2017, six SEER registries recruited both recently diagnosed and longer-term survivors with early age-onset multiple myeloma or colorectal, breast, prostate, or ovarian cancer. Potential participants were asked to complete a survey, providing data on demographics, health, and their willingness to participate in various aspects of research studies.
Response rates across the registries ranged from 24.9% to 46.9%, with sample sizes of 115 to 239 enrolled by each registry over a 12- to 18-month period. Among the 992 total respondents, 90% answered that they would be willing to fill out a survey for a future research study, 91% reported that they would donate a biospecimen of some type, and approximately 82% reported that they would consent to have their medical records accessed for research.
This study demonstrated the feasibility of leveraging SEER registries to recruit a geographically and racially diverse group of cancer survivors.
Central cancer registries are a source of high-quality data that can be utilized to conduct population-based cancer survivor studies.
Details
- Title: Subtitle
- Utilizing SEER Cancer Registries for Population-Based Cancer Survivor Epidemiologic Studies: A Feasibility Study
- Creators
- Lisa Gallicchio - Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland. lisa.gallicchio@nih.govJoanne W Elena - Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MarylandSarah Fagan - Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MarylandMarjorie Carter - Utah Cancer Registry, University of Utah, Salt Lake City, UtahAnn S Hamilton - Department of Preventive Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, CaliforniaTheresa A Hastert - Population Studies and Disparities Research Program, Karmanos Cancer Institute, Detroit, MichiganLisa L Hunter - Iowa Cancer Registry, University of Iowa College of Public Health, Iowa City, IowaJie Li - New Jersey State Cancer Registry, State of New Jersey, Department of Health, Trenton, New JerseyCharles F Lynch - Cancer Epidemiology and Population Science Program, Holden Comprehensive Cancer Center, Iowa City, IowaJoel Milam - Department of Preventive Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, CaliforniaMorgan M Millar - Department of Internal Medicine, University of Utah, Salt Lake City, UtahDenise Modjeski - Department of Preventive Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, CaliforniaLisa E Paddock - Rutgers Cancer Institute of New Jersey, New Brunswick, New JerseyAmanda R Reed - Population Studies and Disparities Research Program, Karmanos Cancer Institute, Detroit, MichiganLisa B Moses - Louisiana Tumor Registry, Louisiana State University School of Public Health, New Orleans, LouisianaAntoinette M Stroup - Rutgers Cancer Institute of New Jersey, New Brunswick, New JerseyCarol Sweeney - Huntsman Cancer Institute, University of Utah, Salt Lake City, UtahEdward J Trapido - Department of Epidemiology, Louisiana State University Health Sciences Center School of Public Health, New Orleans, LouisianaMichele M West - Cancer Epidemiology and Population Science Program, Holden Comprehensive Cancer Center, Iowa City, IowaXiao-Cheng Wu - Louisiana Tumor Registry, Louisiana State University School of Public Health, New Orleans, LouisianaKathy J Helzlsouer - Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland
- Resource Type
- Journal article
- Publication Details
- Cancer epidemiology, biomarkers & prevention, Vol.29(9), pp.1699-1709
- DOI
- 10.1158/1055-9965.EPI-20-0153
- PMID
- 32651214
- PMCID
- PMC7484198
- NLM abbreviation
- Cancer Epidemiol Biomarkers Prev
- ISSN
- 1055-9965
- eISSN
- 1538-7755
- Grant note
- HHSN261201300011I / NCI NIH HHS P30 ES005605 / NIEHS NIH HHS HHSN261201300004I / NCI NIH HHS HHSN261201300020C / NCI NIH HHS HHSN261201300016I / NCI NIH HHS HHSN261201300020I / NCI NIH HHS Z99 CA999999 / Intramural NIH HHS HHSN261201300011C / CCR NIH HHS P30 CA086862 / NCI NIH HHS HHSN261201300021C / NCI NIH HHS HHSN261201300016C / NCI NIH HHS
- Language
- English
- Date published
- 09/2020
- Academic Unit
- Epidemiology
- Record Identifier
- 9984214823402771
Metrics
7 Record Views